MX2014007122A - Nuevos glucosaminoglucanos con baja actividad anticoagulante. - Google Patents

Nuevos glucosaminoglucanos con baja actividad anticoagulante.

Info

Publication number
MX2014007122A
MX2014007122A MX2014007122A MX2014007122A MX2014007122A MX 2014007122 A MX2014007122 A MX 2014007122A MX 2014007122 A MX2014007122 A MX 2014007122A MX 2014007122 A MX2014007122 A MX 2014007122A MX 2014007122 A MX2014007122 A MX 2014007122A
Authority
MX
Mexico
Prior art keywords
coagulative
glycosaminoglycans
medical use
disaccharide unit
repeating disaccharide
Prior art date
Application number
MX2014007122A
Other languages
English (en)
Other versions
MX351104B (es
Inventor
Hans-Peter Ekre
Ulf Lindahl
Erik Holmer
Per-Olov Eriksson
Original Assignee
Dilafor Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48668970&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2014007122(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Dilafor Ab filed Critical Dilafor Ab
Publication of MX2014007122A publication Critical patent/MX2014007122A/es
Publication of MX351104B publication Critical patent/MX351104B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La presente invención se refiere a un glucosaminoglucano químicamente modificado con una actividad antifactor II de menos de 10 UI/mg, una actividad antifactor Xa de menos de 10 UI/mg y un peso molecular promedio (promedio en peso, Mw) de desde aproximadamente 4,6 hasta 6,9 kDa. También se divulga un procedimiento de preparación del glucosaminoglucano modificado y sus usos médicos.
MX2014007122A 2011-12-19 2012-12-19 Nuevos glucosaminoglucanos con baja actividad anticoagulante. MX351104B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161577223P 2011-12-19 2011-12-19
PCT/SE2012/051433 WO2013095279A1 (en) 2011-12-19 2012-12-19 Non anti-coagulative glycosaminoglycans comprising repeating disaccharide unit and their medical use

Publications (2)

Publication Number Publication Date
MX2014007122A true MX2014007122A (es) 2015-03-05
MX351104B MX351104B (es) 2017-10-02

Family

ID=48668970

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014007122A MX351104B (es) 2011-12-19 2012-12-19 Nuevos glucosaminoglucanos con baja actividad anticoagulante.

Country Status (28)

Country Link
US (1) US9475888B2 (es)
EP (1) EP2794665B1 (es)
JP (2) JP6543467B2 (es)
KR (1) KR102135485B1 (es)
CN (1) CN104144950B (es)
AU (1) AU2012354229B2 (es)
BR (1) BR112014014454B1 (es)
CA (1) CA2856492C (es)
CL (1) CL2014001651A1 (es)
CO (1) CO7061069A2 (es)
CY (1) CY1119899T1 (es)
DK (1) DK2794665T3 (es)
ES (1) ES2656613T3 (es)
HK (1) HK1202883A1 (es)
HR (1) HRP20180124T1 (es)
HU (1) HUE036523T2 (es)
IL (1) IL232905A (es)
LT (1) LT2794665T (es)
ME (1) ME02994B (es)
MX (1) MX351104B (es)
NO (1) NO2904345T3 (es)
PL (1) PL2794665T3 (es)
PT (1) PT2794665T (es)
RS (1) RS56874B1 (es)
RU (1) RU2617764C2 (es)
SI (1) SI2794665T1 (es)
WO (1) WO2013095279A1 (es)
ZA (1) ZA201403640B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
RU2014143017A (ru) * 2012-03-26 2016-05-20 Дилафор Аб Препараты для индукции родов
RU2014143008A (ru) * 2012-03-26 2016-05-20 Дилафор Аб Способ лечения остановки родов
UA117912C2 (uk) * 2012-05-08 2018-10-25 Ділафор Аб Застосування гепарину або гепарансульфату для лікування післяпологової кровотечі (ппк)
GB2515315A (en) * 2013-06-19 2014-12-24 Dilafor Ab New Processes
CN103788222B (zh) * 2014-01-08 2016-08-31 中国科学院昆明植物研究所 Fuc3S4S取代的低聚糖胺聚糖及其制备方法
CN107001488B (zh) * 2014-04-30 2020-05-12 新加坡科技研究局 硫酸乙酰肝素
CN108424474B (zh) * 2017-02-15 2023-07-25 清华大学 去抗凝肝素衍生物及其用于炎症性肠病的治疗
IL295184A (en) 2020-02-17 2022-09-01 Dilafor Ab Tapoxiferine for the treatment of preeclampsia
EP4272749A1 (en) 2022-05-03 2023-11-08 Dilafor AB New medical use of tafoxiparin
AR129190A1 (es) 2022-05-03 2024-07-31 Dilafor Ab Nuevo uso médico de la tafoxiparina

Family Cites Families (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1136620A (en) 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
JPS63246396A (ja) * 1987-03-31 1988-10-13 Shiseido Co Ltd モノクロ−ナル抗体
FR2614026B1 (fr) * 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
SE9002550D0 (sv) 1990-08-01 1990-08-01 Kabivitrum Ab Heparinfragment
SE9003181D0 (sv) 1990-10-04 1990-10-04 Kabivitrum Ab Use of heparin fraction
US5280016A (en) 1991-03-29 1994-01-18 Glycomed Incorporated Non-anticoagulant heparin derivatives
US5250519A (en) 1991-03-29 1993-10-05 Glycomed Incorporated Non-anticoagulant heparin derivatives
JPH0532703A (ja) * 1991-07-26 1993-02-09 Terumo Corp 低分子量ヘパリン誘導体の製造法
AU5442594A (en) * 1992-10-13 1994-05-09 Virginia Commonwealth University Use of non-anticoagulant heparin for treating ischemia/reperfusion injury
US5527785A (en) 1993-05-14 1996-06-18 The Regents Of The University Of California Selectin receptor modulating compositions
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
GB2299998B (en) * 1995-03-31 1997-03-26 Hamilton Civic Hospitals Res Compositions for inhibiting thrombogenesis
US5993810A (en) 1996-03-15 1999-11-30 Lebovitz; Shamir Israel Method of softening or ripening the cervix of a female mammal using collagenase
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
CA2240328A1 (en) 1996-10-15 1998-04-23 Toray Industries, Inc. Cervical canal maturing agent
GB9711443D0 (en) * 1997-06-03 1997-07-30 Leo Pharm Prod Ltd Chemical suppositions
JP3342007B2 (ja) * 1997-11-20 2002-11-05 郁男 山科 低分子ヘパリン修飾体及び皮膚潰瘍治療剤
US6596705B1 (en) 1998-02-09 2003-07-22 The Regents Of The University Of California Inhibition of L-selectin and P-selection mediated binding using heparin
WO1999043714A1 (fr) 1998-02-26 1999-09-02 Seikagaku Corporation Nouveaux derives de polysaccharide, leur procede de production, et compositions medicinales contenant ces nouveaux derives comme principe actif
US6028061A (en) 1998-06-18 2000-02-22 Children's Medical Center Corp Angiogenesis inhibitors and use thereof
KR20010030803A (ko) * 1998-07-31 2001-04-16 야마야 와따루 신규 글리코사미노글리칸 및 이를 함유하는 의약 조성물
WO2000013019A1 (en) * 1998-08-26 2000-03-09 The Collaborative Group, Ltd. Receptor for underivatized, aqueous soluble beta-(1,3)-glucan
MXPA02000142A (es) * 1999-06-30 2003-07-21 Hamilton Civic Hospitals Res Composiciones de heparina que inhiben los factores de coagulacion asociados con el coagulo.
JP4897991B2 (ja) * 1999-07-23 2012-03-14 ラボラトリオス ファルマセウティコス ロビ ソシエダッド アノニマ 超低分子量ヘパリン組成物
IT1316986B1 (it) 2000-01-25 2003-05-26 Sigma Tau Ind Farmaceuti Derivati glicosamminoglicani parzialmente desolfatati nonanticoagulanti ad attivita' antiangiogenica.
JP4585072B2 (ja) * 2000-02-29 2010-11-24 扶桑薬品工業株式会社 ヘパリン解重合法、解重合ヘパリン、その誘導体および医薬組成物
CA2422059C (en) * 2000-09-12 2012-05-15 Massachusetts Institute Of Technology Methods and products related to low molecular weight heparin
SE521676C2 (sv) * 2002-01-02 2003-11-25 Dilafor Ab Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet
EP1542704A1 (en) 2002-04-18 2005-06-22 Stephen H. Embury Method and composition for preventing pain in sickle cell patients
US8071569B2 (en) 2002-09-20 2011-12-06 Mousa Shaker A Oxidized heparin fractions and their use in inhibiting angiogenesis
JP2005106694A (ja) * 2003-09-30 2005-04-21 Mochida Pharmaceut Co Ltd 敗血症早期検出及び重篤度評価
EP1582531A1 (en) 2004-03-24 2005-10-05 Aventis Pharma S.A. Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
US20060040896A1 (en) * 2004-08-18 2006-02-23 Paringenix, Inc. Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity
US7741311B2 (en) 2005-01-03 2010-06-22 Shaker Mousa Composition and method for treating occlusive vascular diseases, nerve regeneration, and wound healing
CA2616230A1 (en) 2005-07-22 2007-02-01 Trf Pharma, Inc. Method for treating sickle cell disease and sickle cell disease sequelae
JP2009507209A (ja) * 2005-07-22 2009-02-19 ザ レジェンツ オブ ザ ユニヴァースティ オブ カリフォルニア ヘパリン組成物およびセレクチン阻害
AU2007233320B2 (en) * 2006-04-04 2013-12-12 Singulex, Inc. Highly sensitive system and methods for analysis of troponin
CA2652205A1 (en) * 2006-05-25 2007-12-06 Mallik Sundaram Low molecular weight heparin composition and uses thereof
WO2009007224A1 (en) * 2007-07-10 2009-01-15 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Low molecular weight heparin derivatives having neuroprotective activity
US8592393B2 (en) * 2007-11-02 2013-11-26 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
JP5572095B2 (ja) * 2007-11-02 2014-08-13 モメンタ ファーマシューティカルズ インコーポレイテッド 非抗凝固性多糖組成物
US8569262B2 (en) 2007-11-02 2013-10-29 Momenta Pharmaceuticals, Inc. Polysaccharide compositions and methods of use for the treatment and prevention of disorders associated with progenitor cell mobilization
EP2205642B1 (en) 2007-11-02 2016-01-27 Momenta Pharmaceuticals, Inc. Non-anticoagulant polysaccharide compositions
WO2009073184A1 (en) 2007-12-03 2009-06-11 Florida State University Research Foundation, Inc. Compositions for inducing labor and associated methods
CN102177180A (zh) 2008-04-04 2011-09-07 犹他州大学研究基金会 烷基化半合成的糖胺聚糖醚及其制备和使用方法
CN102361911A (zh) * 2009-03-27 2012-02-22 阿克塔马克斯手术器材有限责任公司 聚甘油醛
EP2419736B1 (en) 2009-04-16 2014-01-29 Momenta Pharmaceuticals, Inc. Methods of assessing activity of a polysaccharide composition
AU2010268756A1 (en) 2009-06-30 2012-01-19 The Walter And Eliza Hall Institute Of Medical Research Sulfated polysaccharides having antiplasmodial activity and methods and products for identifying antiplasmodial activity
PE20121643A1 (es) * 2009-07-31 2012-11-25 Bayer Healthcare Llc Polipeptidos del factor ix modificados y usos de los mismos
EP2515957B1 (en) * 2009-12-22 2015-07-29 Lifebond Ltd Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
RU2014143008A (ru) 2012-03-26 2016-05-20 Дилафор Аб Способ лечения остановки родов
RU2014143017A (ru) 2012-03-26 2016-05-20 Дилафор Аб Препараты для индукции родов

Also Published As

Publication number Publication date
IL232905A0 (en) 2014-07-31
CY1119899T1 (el) 2018-06-27
PL2794665T3 (pl) 2018-04-30
BR112014014454A2 (pt) 2017-06-13
IL232905A (en) 2017-02-28
HUE036523T2 (hu) 2018-07-30
HRP20180124T1 (hr) 2018-02-23
JP2015500388A (ja) 2015-01-05
EP2794665B1 (en) 2017-11-22
NO2904345T3 (es) 2018-07-21
DK2794665T3 (da) 2018-01-29
RU2014129816A (ru) 2016-02-20
MX351104B (es) 2017-10-02
KR102135485B1 (ko) 2020-07-17
JP6543467B2 (ja) 2019-07-10
AU2012354229B2 (en) 2016-12-01
EP2794665A4 (en) 2015-08-26
US20150011505A1 (en) 2015-01-08
KR20140113652A (ko) 2014-09-24
CO7061069A2 (es) 2014-09-19
PT2794665T (pt) 2018-01-24
WO2013095279A1 (en) 2013-06-27
CL2014001651A1 (es) 2014-10-10
CA2856492C (en) 2017-01-10
CN104144950B (zh) 2017-09-05
EP2794665A1 (en) 2014-10-29
RS56874B1 (sr) 2018-04-30
CA2856492A1 (en) 2013-06-27
LT2794665T (lt) 2017-12-27
ZA201403640B (en) 2017-06-28
US9475888B2 (en) 2016-10-25
ES2656613T3 (es) 2018-02-27
JP2018111825A (ja) 2018-07-19
CN104144950A (zh) 2014-11-12
HK1202883A1 (en) 2015-10-09
RU2617764C2 (ru) 2017-04-26
SI2794665T1 (en) 2018-03-30
AU2012354229A1 (en) 2014-06-05
ME02994B (me) 2018-10-20
BR112014014454B1 (pt) 2021-03-09

Similar Documents

Publication Publication Date Title
MX2014007122A (es) Nuevos glucosaminoglucanos con baja actividad anticoagulante.
IN2014MN01056A (es)
MX2014007934A (es) Composicion de farmaco de carbohidrato novedoso para el tratamiento de enfermedades humanas.
WO2014018596A3 (en) Alpha (1,2) fucosyltransferases suitable for use in the production of fucosylated oligosaccharides
TN2010000086A1 (en) Antiviral composition comprising a sulfated polysaccharide
MX358491B (es) Una composicion farmacéutica para tratar cáncer, que comprende un conjugado de interferón alfa.
MX2011009133A (es) Composicion dentifrica.
LT2429515T (lt) Nauji vaistai, skirti vietiniam naudojimui sulfatuotos hialurono rūgšties, kaip citokinų aktyvumą aktyvuojančio arba inhibuojančio agento, pagrindu
BR112015013774A2 (pt) membrana de hidrogel para prevenção de adesão
WO2018056937A3 (en) Nanofibrous adhesion barrier
PH12014502680A1 (en) Polysaccharide compositions and methods of use
NZ603479A (en) Chitosan composition
MX2012007166A (es) Composicion antiviral sinergica y su uso.
NZ595969A (en) Use of galacto-oligosaccharide in the prevention of an inflammatory disorder
MX2019009711A (es) Mejoras en o con respecto a compuestos organicos.
NZ631279A (en) Method for treatment of labor arrest
JP2007126453A5 (es)
WO2013160349A3 (en) Cosmetic composition comprising a phosphorylated oligosaccharide and a polysaccharide
IN2015DN02358A (es)
TR201908669T4 (tr) N-desülfatlanmış glikozaminoglikanların türevleri ve ilaç olarak kullanımı.
RU2016116786A (ru) Иммуностимулятор
BR112013009185A2 (pt) uso de mexiprostil no tratamento de doença inflamatória intestinal e/ou de síndrome do intestino irritável.
CY1121569T1 (el) Καρβοξυλιωμενα παραγωγα γλυκοζαμινογλυκανων και χρηση ως φαρμακα
MX2015013122A (es) Composiciones hidrofílicas de hialuronato modificado, revestimientos y métodos.
WO2010086617A3 (en) Phosphoantigens for the treatment of burkholderia infections

Legal Events

Date Code Title Description
FG Grant or registration